Filing Details

Accession Number:
0001610717-23-000290
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-19 21:47:02
Reporting Period:
2023-09-19
Accepted Time:
2023-09-19 21:47:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1885522 Neumora Therapeutics Inc. NMRA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1659625 O Henry Gosebruch C/O Neumora Therapeutics, Inc.
490 Arsenal Way, Suite 200
Watertown MA 02472
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-19 15,000 $12.62 15,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 127,448 Indirect See Footnote
Common Stock 382,345 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.465 to $12.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
  2. Shares held by HG4KYC TRUST, of which Reporting Person is trustee.
  3. Shares held by Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust, of which Reporting Person is trustee.